A top US health regulator said that it was possible data from trials could be available to interpret as early as October.Pfizer said that its vaccine is on track to be submitted for regulatory review as early as October
from Livemint - Science https://ift.tt/2Q9IjyD
https://ift.tt/eA8V8J
from Livemint - Science https://ift.tt/2Q9IjyD
https://ift.tt/eA8V8J
إرسال تعليق